Overview

A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

Status:
Completed
Trial end date:
2021-09-28
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate the effects on QT/QTc Interval of TS-142 in Healthy Adult Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Taisho Pharmaceutical Co., Ltd.
Treatments:
Moxifloxacin